Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
Puri A, Pollard AJ, Schmidt-Mutter C, Lainé F, PrayGod G, Kibuuka H, Barry H, Nicolas JF, Lelièvre JD, Sirima SB, Kamala B, Manno D, Watson-Jones D, Gaddah A, Keshinro B, Luhn K, Robinson C, Douoguih M; EBL4001 Study Group. Puri A, et al. Vaccines (Basel). 2024 Feb 17;12(2):210. doi: 10.3390/vaccines12020210. Vaccines (Basel). 2024. PMID: 38400193 Free PMC article.
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
Pollard AJ, Launay O, Lelievre JD, Lacabaratz C, Grande S, Goldstein N, Robinson C, Gaddah A, Bockstal V, Wiedemann A, Leyssen M, Luhn K, Richert L, Bétard C, Gibani MM, Clutterbuck EA, Snape MD, Levy Y, Douoguih M, Thiebaut R; EBOVAC2 EBL2001 study group. Pollard AJ, et al. Lancet Infect Dis. 2021 Apr;21(4):493-506. doi: 10.1016/S1473-3099(20)30476-X. Epub 2020 Nov 17. Lancet Infect Dis. 2021. PMID: 33217361 Clinical Trial.
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects.
Hanes V, Chow V, Stewart T, Puri A. Hanes V, et al. Among authors: puri a. Cancer Chemother Pharmacol. 2021 Nov;88(5):879-886. doi: 10.1007/s00280-021-04334-x. Epub 2021 Aug 5. Cancer Chemother Pharmacol. 2021. PMID: 34355250 Free PMC article. Clinical Trial.
Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study.
Stojcheva N, Gladman S, Soergel M, Zitt C, Drake R, Lockett T, Marchand C, Fustier P, Stavropoulou V, Fernandez E, Pettigiani NL, Watkins K, Puri A, Watson R, Legenne P, Stumpp MT, Boyce M. Stojcheva N, et al. Among authors: puri a. Br J Clin Pharmacol. 2023 Jul;89(7):2295-2303. doi: 10.1111/bcp.15747. Epub 2023 May 8. Br J Clin Pharmacol. 2023. PMID: 37057679 Clinical Trial.
Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke.
Mujanovic A, Strbian D, Demeestere J, Marto JP, Puetz V, Nogueira RG, Abdalkader M, Nagel S, Raymond J, Ribo M, Michel P, Yoshimura S, Zaidat OO, Winzer S, Ortega-Gutierrez S, Sheth SA, Siegler JE, Dusart A, Haussen DC, Henon H, Serrallach BL, Mohammaden MH, Möhlenbruch MA, Olive-Gadea M, Puri AS, Sakai N, Klein P, Tomppo L, Caparros F, Ramos JN, Jumaa M, Zaidi S, Dobrocky T, Martinez-Majander N, Nannoni S, Bellante F, Rodriguez-Calienes A, Salazar-Marioni S, Virtanen P, Kaiser DP, Ventura R, Jesser J, Castonguay AC, Qureshi MM, Masoud HE, Galecio-Castillo M, Requena M, Lauha R, Hu W, Lin E, Miao Z, Roy D, Yamagami H, Seiffge DJ, Strambo D, Ringleb PA, Lemmens R, Fischer U, Nguyen TN, Kaesmacher J. Mujanovic A, et al. Among authors: puri as. Eur Stroke J. 2024 May 17:23969873241249406. doi: 10.1177/23969873241249406. Online ahead of print. Eur Stroke J. 2024. PMID: 38757713 Free article.
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe.
Pereira VM, Lylyk P, Cancelliere N, Lylyk PN, Lylyk I, Anagnostakou V, Bleise C, Nishi H, Epshtein M, King RM, Shazeeb MS, Puri AS, Liang CW, Hanel RA, Spears J, Marotta TR, Lopes DK, Gounis MJ, Ughi GJ. Pereira VM, et al. Among authors: puri as. Sci Transl Med. 2024 May 15;16(747):eadl4497. doi: 10.1126/scitranslmed.adl4497. Epub 2024 May 15. Sci Transl Med. 2024. PMID: 38748771
1,212 results